Not seeing the results that match your search? FILTER BY CATEGORY AND FIELD
Dr. Michael Ison
Northwestern University Feinberg School of Medicine
Professor, Divisions of Infectious Diseases and Organ Transplantation
Areas of Focus
- Influenza (flu) and other respiratory viruses in hospitalized and immunocompromised adults
- Post-transplant infections and donor-derived infections
- Determining how to prevent and treat influenza in immunocompromised patients
- Involved in the The National Institute of Allergy and Infectious Diseases (NIAID) Influenza Research Collaboration, which aims to to develop more durable, broadly protective and longer-lasting influenza vaccines, and has helped to design two of the group’s current studies
- Management of influenza in low-risk ambulatory adults
Dr. Michael Ison completed his medical school training at University of South Florida College of Medicine and the obtained training in Internal Medicine at Oregon Health Sciences University in Portland, Oregon followed by Infectious Diseases at the University of Virginia. He joined the faculty of the Divisions of Infectious Diseases and Organ Transplantation at Northwestern University Feinberg School of Medicine in 2005. He is currently the Medical Director of the Transplant & Immunocompromised Host Infectious Diseases Service, Northwestern University Comprehensive Transplant Center.
He has recently provided advice to the President’s H1N1 Subcommittee, NIH and BARDA on issues related to influenza in hospitalized and immunocompromised patients. He was a key opinion leader in the development of peramivir, in addition to several other anti-influenza antivirals currently under development. Additionally, Dr. Isosn is a member of the IDSA/CDC and WHO influenza treatment guideline revision committees, and is currently the co-chair of the Antiviral Group of the International Society of Influenza and Other Respiratory Viruses.
Dr. Ison has also been a leader in the Transplant Infectious Diseases arena. He is a past member of the Executive Committee of the American Society for Transplantation’s Transplant Infectious Diseases Study Group, a past member of the AST Infectious Diseases Community of Practice Executive Committee and chaired the United Network for Organ Sharing’s Disease Transmission Advisory Committee from 2006 – 2010. He has been a member and is the past chair of the Advisory Committee on Blood Safety and Availability. He is also a past At Large representatives on the OPTN/UNOS Board of Directors and current member of the American Society of Transplantation Board of Directors. He is currently the President of the Transplant Infectious Diseases Section of the Transplantation Society. He, too, has been involved globally as the chair of the Infectious Diseases Editorial Group for the CNT/WHO Project NOTIFY Library and the past leader of the Infectious Diseases group of the World Health Organization Bologna Initiative on Global Vigilance and Surveillance.